We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.00
Bid: 27.00
Ask: 30.00
Change: 1.00 (3.64%)
Spread: 3.00 (11.111%)
Open: 27.50
High: 28.50
Low: 27.50
Prev. Close: 27.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

20 Apr 2020 07:00

RNS Number : 1077K
Bacanora Lithium PLC
20 April 2020
 

20 April 2020

Bacanora Lithium plc

("Bacanora" or the "Company")

 

Appointment of Non-Executive Director

 

Bacanora Lithium plc (AIM: BCN), a lithium exploration and development company, is pleased to announce that Mr. Graeme Purdy has been appointed as an independent Non-Executive Director of the Company with immediate effect. Graeme is the Chief Executive Officer of Ilika Plc (AIM: IKA) ("Ilika"), a solid-state lithium battery technology developer. He is a hands-on manager with over 25 years of global experience in the resources and battery industries.

Under Graeme's leadership, Ilika has grown to be one of the few independent global companies specialising in the design and manufacture of solid-state lithium ion batteries. As a result, Graeme is a recognised thought leader in the industry speaking regularly at trade and investor events. Of additional relevance to Bacanora's current activities, is Graeme's experience from his earlier international career with Shell, where he managed the design, construction and commissioning of large process engineering projects in remote locations, including Latin America. Graeme holds a Master's degree in Chemical Engineering from Cambridge and an MBA from INSEAD business school in France. He is a Chartered Engineer, a Fellow of the Institute of Chemical Engineers and a Sainsbury Management Fellow.

Mark Hohnen, Chairman of Bacanora, commented: 

"I am delighted that Graeme Purdy has agreed to join the board of Bacanora. He brings with him a wealth of engineering and technical expertise from the battery industry, as well as experience in the UK capital markets via Ilika Plc. This appointment strengthens Bacanora's board further as the Company embarks on the next phase of its development, as it looks to finance and build its flagship asset, the Sonora Lithium Project, in Mexico."

Commenting on his appointment, Graeme Purdy said:

"I am pleased to be joining Bacanora's board at this exciting time for the Company as it develops into a world class lithium producer. I have been impressed by Bacanora's achievements, particularly more recently with the arrival of Ganfeng Lithium, the world's largest lithium metals producer, as a major shareholder and offtake partner, in conjunction with the Company's existing offtake partner Hanwa Corporation. I look forward to being part of the board and lending my support and expertise to further the Company's growth and ambitions."

 

The following information is disclosed in respect of Mr Purdy (age 54) pursuant to Schedule 2(g) of the AIM Rules for Companies:

Current Directorships

Directorships and partnerships held in the past five years

Ilika Technologies Ltd

None

Ilika Plc

 

Mr. Graeme Purdy does not hold any ordinary shares nor options over ordinary shares in the Company.

There is no further information which is required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies in respect of Mr. Graeme Purdy.

** ENDS **

For further information please visit www.bacanoralithium.com or contact:

Bacanora Lithium plc

Peter Secker, CEO

Janet Blas, CFO

 

info@bacanoralithium.com

Cairn Financial Advisers LLP, Nomad

Sandy Jamieson / Liam Murray

 

+44 (0) 20 7213 0880

Citigroup Global Markets, Joint Broker

Tom Reid / Patrick Evans / Matthew Kenney

 

+44 (0) 20 7986 4000

Canaccord Genuity, Joint Broker

James Asensio / Edward Montgomery

 

+44 (0) 20 7523 8000

Tavistock, Financial PR Adviser

Jos Simson / Emily Moss / Oliver Lamb

Bacanora@tavistock.co.uk

+44 (0) 20 7920 3150

+44 (0) 77 8855 4035

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

Notes to editors

Bacanora Lithium Plc is an AIM-listed (ticker 'BCN') lithium development and exploration company. The Company owns assets in Mexico and Germany. It is focused on building, in collaboration with its major shareholder and offtake partner, Ganfeng Lithium (the world's largest lithium metals producer), a 35,000 tonne per annum open pit lithium carbonate operation at its flagship asset, the Sonora Lithium Project in Mexico. The Sonora Lithium Project has 8.8 million tonnes of lithium carbonate (Li2CO3) equivalent resources, with an approximate 250 year resource life, as detailed in its December 2017 Feasibility Study.

 

Sonora Lithium Ltd ("SLL") is the operational holding company for the Sonora Lithium Project and owns 100% of the La Ventana concession. The La Ventana concession accounts for 88% of the mined ore feed in the Sonora Feasibility Study which covers the initial 19 years of the project mine life. SLL is owned 77.5% by Bacanora and 22.5% by Ganfeng Lithium Ltd. SLL also owns 70% of the El Sauz and Fleur concessions. 

 

In addition, the Company has a 50% interest in the Zinnwald Lithium Project and the Falkenhain and Altenberg Licences in southern Saxony, Germany.

 

Important notice

The contents of this announcement have been prepared by and are the sole responsibility of Bacanora.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGPUAGCUPUGRM
Date   Source Headline
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn
17th Nov 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.